Bile acid sulfonate and 7-alkylated bile acid analogs: Effect on intestinal absorption of taurocholate and cholesterol 7α-hydroxylase activity in cultured rat hepatocytes

Steroids

Volumn 65, Issue 1, 2000, Pages 24-28

  Kim, Hyun Guell ^a   Une, Mizuho ^a   Hino, Akinobu ^a   Wada, Hiroko ^a   Yoshii, Michiko ^a   Kuramoto, Taiju ^a   Fujimura, Kingo ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Bile acid analogs; Bile acids; Cholesterol 7 hydroxylase; Cultured hepatocytes; Intestinal absorption

Indexed keywords

BILE ACID; CHENODEOXYCHOLIC ACID; CHENODEOXYCHOLIC ACID DERIVATIVE; CHOLESTEROL 7ALPHA MONOOXYGENASE; CHOLIC ACID DERIVATIVE; LACTATE DEHYDROGENASE; TAUROCHOLIC ACID; URSODEOXYCHOLIC ACID DERIVATIVE;

ANIMAL CELL; ARTICLE; BILE ACID METABOLISM; CHEMICAL MODIFICATION; CHOLESTEROL METABOLISM; DRUG METABOLISM; ENTEROHEPATIC CIRCULATION; ILEUM; INTESTINE ABSORPTION; LIVER CELL; MALE; NONHUMAN; RAT;

ANIMALS; BILE ACIDS AND SALTS; CELLS, CULTURED; CHOLESTEROL 7-ALPHA-HYDROXYLASE; ILEUM; INTESTINAL ABSORPTION; L-LACTATE DEHYDROGENASE; LIVER; MALE; RATS; SULFONIC ACIDS; TAUROCHOLIC ACID;

EID: 0033990326     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(99)00075-6     Document Type: Article

References (22)

1. Danzinger R.G., Hofmann A.F., Schoenfield L.J., Thistle J.L. Dissolution of cholesterol gallstones by chenodeoxycholic acid. N Engl J Med. 286:1972;1-8.
2. Makino I., Shinozaki K., Yoshino K., Nakagawa S. Dissolution of cholesterol gallstones by ursodeoxycholic acid. Jpn J Gastroenterol. 72:1975;690-702.
3. Poupon R, Chretien Y, Poupon R, Ballet F, Calmus Y, Darnis F. Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? Lancet 1987:834-6.
4. Fedorowski T., Salen G., Collalilo A., Tint G.S., Mosbach E.H., Hall J.C. Metabolism of ursodeoxycholic acid in man. Gastroenterology. 73:1977;1131-1137.
5. Palmer R.H. Bile acids, liver injury, and liver disease. Arch Intern Med. 130:1972;606-617.
6. Russo P.M., Taningher M., Pala M., Pisano V., Pedemonte P., Angeli M.T.D., Carlone S., Santi L., Parodi S. Characterization of the effects induced on DNA in mouse and hamster cells by lithocholic acid. Cancer Res. 47:1987;2866-2874.
7. Une M., Singhal A.K., McSherry C.K., May-Donath P., Mosbach E.H. Metabolism of 3α,7α-dihydroxy-7β-methyl-5β-cholanoic acid and 3α,7β-dihydroxy-7α-methyl-5β-cholanoic acid in hamsters. Biochim Biophys Acta. 833:1985;196-202.
8. Une M., Yamanaga K., Mosbach E.H., Tsujimura K., Hoshita T. Metabolism of 7β-alkyl chenodeoxycholic acid analogs and their effect on cholesterol metabolism in hamsters. J Lipid Res. 31:1990;1015-1021.
9. Kihira K., Okamoto A., Ikawa S., Mikami T., Yoshii M., Mosbach E.H., Hoshita T. Metabolism of sodium 3α,7α-dihydroxy-5β-cholane-24-sulfonates in hamsters. J Biochem. 109:1991;879-881.
10. Mikami T., Kihira K., Ikawa S., Yoshii M., Miki S., Mosbach E.H., Hoshita T. Metabolism of sulfonate analogs of ursodeoxycholic acid and their effects on biliary bile acid composition in hamsters. J Lipids Res. 34:1993;429-435.
11. Shefer S., Nguyen L., Salen G., Batta A.K., Brooker D., Zaki F.G., Rani I., Tint G.S. Feedback regulation of bile acids synthesis in the rat. J Clin Invest. 85:1990;1191-1198.
12. Hashim S.A., Van Itallie T.B. Cholestyramine resin therapy for hypercholesterolemia clinical and metabolic studies . JAMA. 192:1965;289-293.
13. Une M., Yamanaga K., Mosbach E.H., Kuroki S., Hoshita T. Synthesis of bile acid analogs 7-alkylated chenodeoxycholic acids . Steroids. 53:1989;97-105.
14. Kihira K., Mikami T., Ikawa S., Okamoto A., Yoshii M., Miki S., Mosbach E.H., Hoshita T. Synthesis of sulfonate analogs of bile acids. Steroids. 57:1992;193-198.
15. Bissell D.M., Guzelian P.S. Phenotypic stability of adult rat hepatocytes in primary monolayer culture. Ann NY Acad Sci. 349:1980;85-98.
16. Yamasita H., Kuroki S., Nakayama F. Assay of cholesterol 7α-hydroxylase utilizing a silica cartridge column and 5a-cholestane-3b,7β-diol as an internal standard. J Chromatogr. 496:1989;255-268.
17. Nakazawa T., Hoshino M., Hayakawa T., Tanaka A., Ohiwa T. Vasopressin reduces taurochenodeoxycholate-induced hepatotoxicity by lowering the hepatocyte taurochenodeoxycholate content. J Hepatol. 25:1996;739-747.
18. Bertolotti M., Abate N., Loria P., Dilengite M., Carubbi F., Pinetti A., Digrisolo A., Carulli N. Regulation of bile acid synthesis in humans effect of treatment with bile acids, cholestyramine or simvastatin on cholesterol 7α-hydroxylation rates in vivo . Hepatology. 14:1991;830-837.
19. Kubaska W.M., Gurley E.C., Hylemon P.B., Heuman D.M., Mosbach E.H., Vlahcevic Z.R. Effect of ursodeoxycholic acid, analogues of ursodeoxycholic acid and combination of bile acid on bile acid synthesis in cultured rat hepatocytes. Biochim Biophys Acta. 920:1987;195-204.
20. Stravitz R.T., Hylemon P.B., Heuman D.M., Hagey L.R., Schteingart C.D., Ton-Nu H.-T., Hofmann A.F., Vlahcevic Z.R. Transcriptional regulation of cholesterol 7α-hydroxylase mRNA by conjugated bile acids in primary cultures of rat hepatocytes. J Biol Chem. 268:1993;13987-13993.
21. Pandak W.M., Vlahcevic Z.R., Heuman D.M., Redford K.S., Chiang J.Y.L., Hylemon P.B. Effects of different bile salts on steady-state mRNA levels and transcriptional activity of cholesterol 7α-hydroxylase. Hepatology. 19:1994;941-947.
22. Sagawa H., Tazuma S., Kajiyama G. Protection against hydrophobic bile salt-induced cell membrane damage by liposomes and hydrophilic bile salts. Am J Physiol. 264:1993;G835-G839.